Multiple endocrine neoplasia type 1 risk factors: Difference between revisions
No edit summary |
|||
Line 10: | Line 10: | ||
:* Positive [[family history]] | :* Positive [[family history]] | ||
:* History of [[Zollinger-Ellison syndrome]] | :* History of [[Zollinger-Ellison syndrome]] | ||
:* [[Pituitary disease|Pituitary dysfunction]] | :* [[Pituitary disease|Pituitary dysfunction]] <ref name="pmid28458907">{{cite journal| author=Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T et al.| title=Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy. | journal=Endocrinol Diabetes Metab Case Rep | year= 2017 | volume= 2017 | issue= | pages= | pmid=28458907 | doi=10.1530/EDM-17-0027 | pmc=5404709 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28458907 }} </ref> | ||
==References== | ==References== |
Revision as of 16:49, 6 October 2017
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 risk factors On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 risk factors |
Multiple endocrine neoplasia type 1 risk factors in the news |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Common risk factors in the development of multiple endocrine neoplasia type-1 are family history, history of Zollinger-Ellison syndrome and pituitary dysfunction.
Risk Factors
- Common risk factors in the development of multiple endocrine neoplasia type-1 include: [1]
- Positive family history
- History of Zollinger-Ellison syndrome
- Pituitary dysfunction [2]
References
- ↑ de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML; et al. (2012). "Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors". Eur J Endocrinol. 167 (2): 181–7. doi:10.1530/EJE-12-0210. PMID 22581216.
- ↑ Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T; et al. (2017). "Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy". Endocrinol Diabetes Metab Case Rep. 2017. doi:10.1530/EDM-17-0027. PMC 5404709. PMID 28458907.